JP2011519893A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519893A5
JP2011519893A5 JP2011507898A JP2011507898A JP2011519893A5 JP 2011519893 A5 JP2011519893 A5 JP 2011519893A5 JP 2011507898 A JP2011507898 A JP 2011507898A JP 2011507898 A JP2011507898 A JP 2011507898A JP 2011519893 A5 JP2011519893 A5 JP 2011519893A5
Authority
JP
Japan
Prior art keywords
particulate carrier
bioactive agent
polymer
nanoparticles
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011507898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/055437 external-priority patent/WO2009135854A2/en
Publication of JP2011519893A publication Critical patent/JP2011519893A/ja
Publication of JP2011519893A5 publication Critical patent/JP2011519893A5/ja
Pending legal-status Critical Current

Links

JP2011507898A 2008-05-06 2009-05-05 生物活性薬の封入 Pending JP2011519893A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5077508P 2008-05-06 2008-05-06
US61/050,775 2008-05-06
US7417108P 2008-06-20 2008-06-20
US61/074,171 2008-06-20
PCT/EP2009/055437 WO2009135854A2 (en) 2008-05-06 2009-05-05 Encapsulation of biologically active agents

Publications (2)

Publication Number Publication Date
JP2011519893A JP2011519893A (ja) 2011-07-14
JP2011519893A5 true JP2011519893A5 (https=) 2012-02-09

Family

ID=43125568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507898A Pending JP2011519893A (ja) 2008-05-06 2009-05-05 生物活性薬の封入

Country Status (11)

Country Link
US (1) US20110059167A1 (https=)
EP (1) EP2271324A2 (https=)
JP (1) JP2011519893A (https=)
CN (1) CN102083423A (https=)
AU (1) AU2009245785A1 (https=)
BR (1) BRPI0912536A2 (https=)
EA (1) EA201001567A1 (https=)
IL (1) IL208666A0 (https=)
MX (1) MX2010012141A (https=)
WO (1) WO2009135854A2 (https=)
ZA (1) ZA201007437B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110064819A1 (en) * 2008-05-06 2011-03-17 Andrew Beaton Encapsulation of biologically active agents
US9802984B2 (en) 2013-06-07 2017-10-31 The Johns Hopkins University Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
EP3377115A2 (en) * 2015-11-20 2018-09-26 AbbVie Deutschland GmbH & Co. KG Surface-modified nanospheres encapsulating antigen-binding molecules
US11491114B2 (en) * 2016-10-12 2022-11-08 Curioralrx, Llc Formulations for enteric delivery of therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3462193A (en) * 1993-02-15 1994-08-29 Shield Research Limited Polyalkylcyanoacrylate nanocapsules
ES2152990T3 (es) * 1993-09-09 2001-02-16 Schering Ag Principios activos y microparticulas que contienen gases.
AU7134898A (en) * 1997-04-17 1998-11-11 Amgen, Inc. Biodegradable microparticles for the sustained delivery of therapeutic drugs
US20030152636A1 (en) * 2000-02-23 2003-08-14 Nanopharm Ag Method of treating cancer
US7332159B2 (en) * 2004-09-30 2008-02-19 Board Of Regents Of The University Of Nebraska Method and composition for inhibiting reperfusion injury in the brain
US7597907B2 (en) * 2004-11-05 2009-10-06 Trustees Of The University Of Pennsylvania Antioxidant polymer nanocarriers for use in preventing oxidative injury

Similar Documents

Publication Publication Date Title
Leyva-Gómez et al. Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art
Mikušová et al. Advances in chitosan-based nanoparticles for drug delivery
Das et al. Stimuli-responsive boron-based materials in drug delivery
US11684585B2 (en) Nanoscale coatings for encapsulation of biological entities
JP6092121B2 (ja) 疎水性分子に誘起された分岐ポリマー凝集体及びその使用
Roggers et al. The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal
Moritz et al. Mesoporous materials as elements of modern drug delivery systems for anti-inflammatory agents: A review of recent achievements
Bacha et al. Dendrimers: Synthesis, encapsulation applications and specific interaction with the stratum corneum—A review
Dimer et al. Inhalable resveratrol microparticles produced by vibrational atomization spray drying for treating pulmonary arterial hypertension
CN103040757B (zh) 核-壳型纳米药物颗粒、其制备方法及应用
JP2010513363A5 (https=)
JP2011519932A5 (https=)
KR20090113852A (ko) 암 치료용 제제
CN103396521B (zh) 两亲性β-环糊精星型聚合物的合成及其胶束化应用
JP2011225600A5 (https=)
CN101703490A (zh) 聚多糖/无机纳米粒子杂化微纳米载药胶囊
JP2011519893A5 (https=)
US20160374950A1 (en) Nanoparticle drug delivery
Davidson et al. Bioinspired silica offers a novel, green, and biocompatible alternative to traditional drug delivery systems
Ji et al. Review of carrier-free self-assembly of anticancer nanodrugs
Vatankhah et al. Seed's morphology-induced core-shell composite particles by seeded emulsion polymerization for drug delivery
Chaudhary et al. Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis
JP2006500387A (ja) 固形ナノ医薬およびその調製方法
Hyjek et al. Metal-organic frameworks for efficient drug adsorption and delivery
Ravinayagam et al. Nanomaterials and their negative effects on human health